GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 87 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,961,000 | +4.1% | 160,182 | +0.4% | 0.00% | 0.0% |
| Q3 2016 | $1,883,000 | +40.4% | 159,599 | +3.6% | 0.00% | 0.0% |
| Q2 2016 | $1,341,000 | +69.3% | 154,094 | +2.6% | 0.00% | +100.0% |
| Q1 2016 | $792,000 | -30.7% | 150,195 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $1,143,000 | -0.9% | 147,358 | +0.6% | 0.00% | -50.0% |
| Q3 2015 | $1,153,000 | -15.3% | 146,524 | -2.5% | 0.00% | 0.0% |
| Q2 2015 | $1,362,000 | -13.6% | 150,283 | +23.8% | 0.00% | 0.0% |
| Q1 2015 | $1,576,000 | -3.8% | 121,391 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $1,639,000 | +50.9% | 120,396 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,086,000 | -32.8% | 121,021 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $1,617,000 | +63.8% | 119,531 | +20.4% | 0.00% | +100.0% |
| Q1 2014 | $987,000 | -23.8% | 99,276 | +1.9% | 0.00% | -50.0% |
| Q4 2013 | $1,295,000 | +7.4% | 97,467 | -1.9% | 0.00% | 0.0% |
| Q3 2013 | $1,206,000 | +54.4% | 99,369 | +31.7% | 0.00% | +100.0% |
| Q2 2013 | $781,000 | – | 75,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
| Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
| Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
| Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
| HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
| Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
| WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
| Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |